SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015333
Filing Date
2019-05-02
Accepted
2019-05-02 16:08:36
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-10q_20190331.htm 10-Q 1889474
2 EX-10.1 rcus-ex101_77.htm EX-10.1 43625
3 EX-31.1 rcus-ex311_11.htm EX-31.1 17650
4 EX-31.2 rcus-ex312_6.htm EX-31.2 17709
5 EX-32.1 rcus-ex321_7.htm EX-32.1 9216
6 EX-32.2 rcus-ex322_9.htm EX-32.2 9245
7 GRAPHIC g5rynejv5jiz000001.jpg GRAPHIC 2426
  Complete submission text file 0001564590-19-015333.txt   6228173

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rcus-20190331.xml EX-101.INS 1258780
9 XBRL TAXONOMY EXTENSION SCHEMA rcus-20190331.xsd EX-101.SCH 45526
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcus-20190331_cal.xml EX-101.CAL 44032
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcus-20190331_def.xml EX-101.DEF 147486
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20190331_lab.xml EX-101.LAB 340616
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20190331_pre.xml EX-101.PRE 265145
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 19791939
SIC: 2834 Pharmaceutical Preparations